Arrowhead Research Corp Stock Nasdaq
Equities
US0427972098
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 126M | Sales 2025 * | 179M | Capitalization | 2.71B |
---|---|---|---|---|---|
Net income 2024 * | -313M | Net income 2025 * | -304M | EV / Sales 2024 * | 18.2 x |
Net cash position 2024 * | 426M | Net cash position 2025 * | 313M | EV / Sales 2025 * | 13.4 x |
P/E ratio 2024 * |
-8.01
x | P/E ratio 2025 * |
-8.55
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.51% |
Latest transcript on Arrowhead Research Corp
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 07-11-30 | |
Director of Finance/CFO | 57 | 08-12-31 | |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglass Given
CHM | Chairman | 71 | 10-11-22 |
Michael Perry
BRD | Director/Board Member | 64 | 11-12-18 |
Adeoye Olukotun
BRD | Director/Board Member | 79 | 20-08-31 |
1st Jan change | Capi. | |
---|---|---|
-2.16% | 103B | |
+0.48% | 95.71B | |
+2.15% | 22.02B | |
-16.70% | 20.9B | |
-9.30% | 17.85B | |
-42.83% | 16.21B | |
-14.98% | 15.52B | |
+3.93% | 13.86B | |
+34.02% | 12.04B |